Twist Bioscience Corp Net Income
| TWST Stock | USD 49.11 1.45 3.04% |
As of the 13th of February 2026, Twist Bioscience has the Risk Adjusted Performance of 0.1621, coefficient of variation of 526.84, and Semi Deviation of 2.91. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Twist Bioscience Corp, as well as the relationship between them.
Twist Bioscience Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.2108 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -69.9 M | -73.4 M | |
| Net Loss | -196.1 M | -186.3 M | |
| Net Loss | -69.9 M | -73.4 M | |
| Net Loss | (1.17) | (1.23) | |
| Net Income Per E B T | 1.16 | 1.10 |
Twist | Net Income | Build AI portfolio with Twist Stock |
The evolution of Net Income for Twist Bioscience Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Twist Bioscience compares to historical norms and industry peers.
Latest Twist Bioscience's Net Income Growth Pattern
Below is the plot of the Net Income of Twist Bioscience Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Twist Bioscience Corp financial statement analysis. It represents the amount of money remaining after all of Twist Bioscience Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Twist Bioscience's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (77.67 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Twist Net Income Regression Statistics
| Arithmetic Mean | (96,879,421) | |
| Coefficient Of Variation | (65.39) | |
| Mean Deviation | 52,897,468 | |
| Median | (71,236,000) | |
| Standard Deviation | 63,350,207 | |
| Sample Variance | 4013.2T | |
| Range | 173.8M | |
| R-Value | (0.56) | |
| Mean Square Error | 2946.5T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | (7,003,883) | |
| Total Sum of Squares | 64212T |
Twist Net Income History
Other Fundumenentals of Twist Bioscience Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Twist Bioscience Net Income component correlations
Twist Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Twist Bioscience is extremely important. It helps to project a fair market value of Twist Stock properly, considering its historical fundamentals such as Net Income. Since Twist Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Twist Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Twist Bioscience's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Twist introduce new products? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share | Quarterly Revenue Growth 0.169 | Return On Assets | Return On Equity |
Investors evaluate Twist Bioscience Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Twist Bioscience's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Twist Bioscience's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Twist Bioscience's market price signifies the transaction level at which participants voluntarily complete trades.
Twist Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Twist Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Twist Bioscience.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Twist Bioscience on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Twist Bioscience Corp or generate 0.0% return on investment in Twist Bioscience over 90 days. Twist Bioscience is related to or competes with Procept Biorobotics, Quidel, Qilian International, Guardian Pharmacy, Mesoblast, Edgewise Therapeutics, and Uniqure NV. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products More
Twist Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Twist Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Twist Bioscience Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.33 | |||
| Information Ratio | 0.1699 | |||
| Maximum Drawdown | 17.57 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 7.7 |
Twist Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Twist Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Twist Bioscience's standard deviation. In reality, there are many statistical measures that can use Twist Bioscience historical prices to predict the future Twist Bioscience's volatility.| Risk Adjusted Performance | 0.1621 | |||
| Jensen Alpha | 0.5683 | |||
| Total Risk Alpha | 0.4066 | |||
| Sortino Ratio | 0.2071 | |||
| Treynor Ratio | 0.2806 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Twist Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Twist Bioscience February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1621 | |||
| Market Risk Adjusted Performance | 0.2906 | |||
| Mean Deviation | 3.1 | |||
| Semi Deviation | 2.91 | |||
| Downside Deviation | 3.33 | |||
| Coefficient Of Variation | 526.84 | |||
| Standard Deviation | 4.06 | |||
| Variance | 16.45 | |||
| Information Ratio | 0.1699 | |||
| Jensen Alpha | 0.5683 | |||
| Total Risk Alpha | 0.4066 | |||
| Sortino Ratio | 0.2071 | |||
| Treynor Ratio | 0.2806 | |||
| Maximum Drawdown | 17.57 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 7.7 | |||
| Downside Variance | 11.07 | |||
| Semi Variance | 8.46 | |||
| Expected Short fall | (3.72) | |||
| Skewness | 0.4243 | |||
| Kurtosis | 1.26 |
Twist Bioscience Corp Backtested Returns
Twist Bioscience is very steady given 3 months investment horizon. Twist Bioscience Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.27, which indicates the firm had a 0.27 % return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.06% are justified by taking the suggested risk. Use Twist Bioscience Corp Semi Deviation of 2.91, coefficient of variation of 526.84, and Risk Adjusted Performance of 0.1621 to evaluate company specific risk that cannot be diversified away. Twist Bioscience holds a performance score of 21 on a scale of zero to a hundred. The entity has a beta of 2.71, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Twist Bioscience will likely underperform. Use Twist Bioscience Corp maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Twist Bioscience Corp.
Auto-correlation | 0.83 |
Very good predictability
Twist Bioscience Corp has very good predictability. Overlapping area represents the amount of predictability between Twist Bioscience time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Twist Bioscience Corp price movement. The serial correlation of 0.83 indicates that around 83.0% of current Twist Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 27.7 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Twist Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Twist Bioscience Corp reported net income of (77.67 Million). This is 122.76% lower than that of the Biotechnology sector and 144.87% lower than that of the Health Care industry. The net income for all United States stocks is 113.6% higher than that of the company.
Twist Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Twist Bioscience's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics of similar companies.Twist Bioscience is currently under evaluation in net income category among its peers.
Twist Bioscience ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Twist Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Twist Bioscience's managers, analysts, and investors.Environmental | Governance | Social |
Twist Bioscience Institutional Holders
Institutional Holdings refers to the ownership stake in Twist Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Twist Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Twist Bioscience's value.| Shares | Goldman Sachs Group Inc | 2025-06-30 | 1.5 M | Citadel Advisors Llc | 2025-06-30 | 1.5 M | Jpmorgan Chase & Co | 2025-06-30 | 1.4 M | Geode Capital Management, Llc | 2025-06-30 | 1.4 M | Thrivent Financial For Lutherans | 2025-06-30 | 1.3 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.2 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.2 M | First Light Asset Management, Llc | 2025-06-30 | 945 K | American Century Companies Inc | 2025-06-30 | 864.4 K | Ark Investment Management Llc | 2025-06-30 | 6.4 M | Blackrock Inc | 2025-06-30 | 6.3 M |
Twist Fundamentals
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (0.32) % | ||||
| Current Valuation | 2.82 B | ||||
| Shares Outstanding | 61.31 M | ||||
| Shares Owned By Insiders | 1.50 % | ||||
| Shares Owned By Institutions | 98.50 % | ||||
| Number Of Shares Shorted | 12.17 M | ||||
| Price To Book | 6.41 X | ||||
| Price To Sales | 7.46 X | ||||
| Revenue | 376.57 M | ||||
| Gross Profit | 202.13 M | ||||
| EBITDA | (52.1 M) | ||||
| Net Income | (77.67 M) | ||||
| Cash And Equivalents | 504.97 M | ||||
| Cash Per Share | 8.93 X | ||||
| Total Debt | 137.32 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | 7.44 X | ||||
| Cash Flow From Operations | (47.63 M) | ||||
| Short Ratio | 9.52 X | ||||
| Earnings Per Share | (1.22) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 49.89 | ||||
| Number Of Employees | 979 | ||||
| Beta | 2.27 | ||||
| Market Capitalization | 2.92 B | ||||
| Total Asset | 641.86 M | ||||
| Retained Earnings | (1.32 B) | ||||
| Working Capital | 241.56 M | ||||
| Net Asset | 641.86 M |
About Twist Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Twist Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.